Masaryk University

Publication Records

česky | in English

Filter publications

    2023

    1. Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
      BOUCHALOVÁ, Pavla, Jan ŠIMONÍK, Petr LAPČÍK, Lucia JANÁČOVÁ, David POTĚŠIL, Ján PODHOREC, Alice HLOBILKOVÁ, Vlad POPOVICI, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma. In Abstract Book of EACR Conference: Cellular Bases for Patient Response to Cancer Therapies, Lyon, Francie 14.-16.11.2023, P12. 2023.
      URL
      Name in Czech: Proteomika nové generace určila potenciální proteinový marker špatné odpovědi na léčbu tyrosin kinázovými inhibitory u metastatických renálních karcinomů
      RIV/00216224:14310/23:00132334 Conference abstract. English. United Kingdom of Great Britain and Northern Ireland.
      Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Šimoník, Jan (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Janáčová, Lucia (703 Slovakia, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hlobilková, Alice (203 Czech Republic) -- Popovici, Vlad (642 Romania, belonging to the institution) -- Hora, Milan (203 Czech Republic) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Fiala, Ondřej (203 Czech Republic) -- Bouchal, Pavel (203 Czech Republic, belonging to the institution)
      Keywords in English: proteomics; metastatic renal cell cancer; tyrosine kinase inhibitors; therapy response; biomarker
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:47.
      More: https://is.muni.cz/publication/2341817/en
    2. Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
      ŠIMONÍK, Jan, Richard ŠTEFANÍK, Pavla BOUCHALOVÁ, Petr LAPČÍK, David POTĚŠIL, Vlad POPOVICI, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response. In Abstract Book of BSRP - EuPA Annual Scientific Meeting, Newcastle upon Tyne, UK, 17.-20.7.2023. 2023.
      URL
      RIV/00216224:14310/23:00132863 Conference abstract. English. United Kingdom of Great Britain and Northern Ireland.
      Šimoník, Jan (203 Czech Republic, belonging to the institution) -- Štefaník, Richard (203 Czech Republic, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Popovici, Vlad (642 Romania, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hora, Milan (203 Czech Republic, belonging to the institution) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Bouchal, Pavel (203 Czech Republic, belonging to the institution)
      Keywords in English: localized RCC; metastatic RCC; therapy response; tyrosin kinase inhibitors; relapse; prognosis; proteomics; LC-DIA-MS/MS
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:48.
      More: https://is.muni.cz/publication/2358197/en
    3. Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
      ŠIMONÍK, Jan, Pavla BOUCHALOVÁ, Richard ŠTEFANÍK, Petr LAPČÍK, David POTĚŠIL, Vlad POPOVICI, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response. In Abstract Book of XVIII. Czech Annual Cancer Research Meeting, Olomouc, CZ, 20.-22.11.2023. 2023. ISBN 978-80-908348-2-8.
      URL
      Name (in English): Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
      RIV/00216224:14310/23:00132860 Conference abstract. English. Czech Republic.
      Šimoník, Jan (203 Czech Republic, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Štefaník, Richard (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Popovici, Vlad (642 Romania, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hora, Milan (203 Czech Republic, belonging to the institution) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Bouchal, Pavel (203 Czech Republic, belonging to the institution)
      Keywords in English: localized RCC; metastatic RCC; therapy response; tyrosin kinase inhibitors; prognosis; relapse; proteomics; LC-DIA-MS/MS
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:49.
      More: https://is.muni.cz/publication/2358159/en
    4. Proteotype classification of renal cell carcinoma for prognosis and therapy response
      ŠIMONÍK, Jan, Richard ŠTEFANÍK, Pavla BOUCHALOVÁ, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Proteotype classification of renal cell carcinoma for prognosis and therapy response. In Doctoral conference 2023, MUNI, Department of Biochemistry. 2023.
      RIV/00216224:14310/23:00132431 Conference abstract. English. Czech Republic.
      Šimoník, Jan (203 Czech Republic, belonging to the institution) -- Štefaník, Richard (203 Czech Republic, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hora, Milan (203 Czech Republic, belonging to the institution) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Bouchal, Pavel (203 Czech Republic, belonging to the institution)
      Keywords in English: renal cell carcinoma
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:49.
      More: https://is.muni.cz/publication/2346617/en
    5. Proteotypová klasifikace renálního karcinomu (Proteotype classification of renal cell carcinoma)
      BOUCHAL, Pavel, Jan ŠIMONÍK, Richard ŠTEFANÍK, Pavla BOUCHALOVÁ, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH and Ondřej FIALA. Proteotypová klasifikace renálního karcinomu (Proteotype classification of renal cell carcinoma). In Sborník abstrakt (Klinická onkologie, ročník 36, Supplementum I), XLVII. Brněnské onkologické dny, Brno, CZ, 1.-3.11.2023, XXXI/81. 2023.
      URL
      Name (in English): Proteotype classification of renal cell carcinoma
      RIV/00216224:14310/23:00132864 Requested lectures. Czech. Czech Republic.
      Bouchal, Pavel (203 Czech Republic, guarantor, belonging to the institution) -- Šimoník, Jan (203 Czech Republic) -- Štefaník, Richard (203 Czech Republic, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hora, Milan (203 Czech Republic) -- Poprach, Alexandr (203 Czech Republic) -- Fiala, Ondřej (203 Czech Republic)
      Keywords in English: localized and metastatic renal cell carcinoma; tyrosine kinase inhibitors; response to treatment; relapse; prognosis
      Type of participation: requested lecture
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:50.
      More: https://is.muni.cz/publication/2358237/en
    6. Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment
      ŠIMONÍK, Jan, Pavla BOUCHALOVÁ, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Lucia JANÁČOVÁ, Alice HLOBILKOVÁ, Vlad POPOVICI, Alexandr POPRACH, Milan HORA, Ondřej FIALA and Pavel BOUCHAL. Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment. In 9th Informal Proteomic Meeting November 30 – December 1, Mělník, Masaryk Cultural House. 2023.
      RIV/00216224:14310/23:00132430 Conference abstract. English. Czech Republic.
      Šimoník, Jan (203 Czech Republic, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Janáčová, Lucia (703 Slovakia, belonging to the institution) -- Hlobilková, Alice (203 Czech Republic, belonging to the institution) -- Popovici, Vlad (642 Romania, belonging to the institution) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Hora, Milan (203 Czech Republic, belonging to the institution) -- Fiala, Ondřej (203 Czech Republic) -- Bouchal, Pavel (203 Czech Republic, belonging to the institution)
      Keywords in English: Transmembrane glycoprotein GPNMB; metastatic renal cell carcinoma; tyrosine kinase receptor inhibitor treatment
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:58.
      More: https://is.muni.cz/publication/2346597/en

    2022

    1. A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
      LAPČÍK, Petr, Lucia JANÁČOVÁ, Pavla BOUCHALOVÁ, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues. Proteomics. Weinheim: Wiley-VCH GmbH, 2022, vol. 22, No 7, p. "e2100228", 7 pp. ISSN 1615-9853. Available from: https://dx.doi.org/10.1002/pmic.202100228.
      URL
      RIV/00216224:14310/22:00125181 Article in a journal. English. Germany.
      Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Janáčová, Lucia (703 Slovakia, belonging to the institution) -- Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Hora, Milan (203 Czech Republic) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Fiala, Ondřej (203 Czech Republic) -- Bouchal, Pavel (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: assay library; data independent acquisition; mass spectrometry; proteomics; renal cell carcinoma
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 5/4/2022 10:50.
      More: https://is.muni.cz/publication/1822322/en
    2. DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
      ŠIMONÍK, Jan, Petr LAPČÍK, Pavla BOUCHALOVÁ, Lucia JANÁČOVÁ, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment. In In Book of Abstracts of 14th European Summer School, Brixen, Italy 31.7.-6.8. 2022, p.46. 2022.
      English. Germany.
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: Ing. Jan Šimoník, učo 473766. Changed: 28/11/2022 10:15.
      More: https://is.muni.cz/publication/2235186/en
    3. Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition
      MARTIŠOVÁ, Andrea, Lucia SOMMEROVÁ, Adam KREJCI, Iveta SELINGEROVÁ, Tamara KOLAROVA, Filip ZAVADIL KOKAS, Miloš HOLÁNEK, Ján PODHOREC, Tomáš KAZDA and Roman HRSTKA. Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences. MDPI, 2022, vol. 23, No 18, p. 1-19. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms231810845.
      URL
      RIV/00216224:14310/22:00126708 Article in a journal. English. Switzerland.
      Martišová, Andrea (703 Slovakia, belonging to the institution) -- Sommerová, Lucia (703 Slovakia) -- Selingerová, Iveta (203 Czech Republic) -- Holánek, Miloš (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia) -- Kazda, Tomáš (203 Czech Republic) -- Hrstka, Roman (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: AGR2; EMT; TGF-β; RNAseq; arachidonic acid; focal adhesion
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/1/2023 09:14.
      More: https://is.muni.cz/publication/2218999/en
    4. Metastatický HR+/HER2- karcinom prsu - léčba inhibitory CDK4/6, data z registru BRESCA
      PALÁCOVÁ, Markéta, Martina ZIMOVJANOVÁ, Petra TESAŘOVÁ, Barbara DONOCIKOVÁ, Ján PODHOREC and Matouš CWIK. Metastatický HR+/HER2- karcinom prsu - léčba inhibitory CDK4/6, data z registru BRESCA. 2022. ISSN 0862-495X.
      Changed by: MUDr. Matouš Cwik, učo 435748. Changed: 20/6/2023 18:10.
      More: https://is.muni.cz/publication/2292887/en
    5. Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory (Proteins associated with low response to tyrosinkinase inhibitor therapy in metastatic kidney tumors)
      BOUCHALOVÁ, Pavla, Jan ŠIMONÍK, David POTĚŠIL, Petr LAPČÍK, Ján PODHOREC, Lucia JANÁČOVÁ, Milan HORA, Alice HLOBILKOVÁ, Alexandr POPRACH, Vlad POPOVICI, Ondřej FIALA and Pavel BOUCHAL. Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory (Proteins associated with low response to tyrosinkinase inhibitor therapy in metastatic kidney tumors). In Sborník abstrakt, přednášek a posterů, XXV. Biologické dny, Brno 5.- 6.9.2022, p. 40. 2022. ISSN 1805-9619.
      stránka konference
      Name in Czech: Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
      Name (in English): Proteins associated with low response to tyrosinkinase inhibitor therapy in metastatic kidney tumors
      Czech. Czech Republic.
      Keywords in English: renal carcinoma, metastases, targeted therapy, sunitinib, resistance, proteomics, GPNMB, migration, invasiveness
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: Mgr. Pavla Bouchalová, Ph.D., učo 53314. Changed: 28/11/2022 14:44.
      More: https://is.muni.cz/publication/2235225/en
    6. Proteotype classification of renal cell carcinoma for prognosis and therapy response
      ŠIMONÍK, Jan, Richard ŠTEFANÍK, Pavla BOUCHALOVÁ, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Proteotype classification of renal cell carcinoma for prognosis and therapy response. In In Book of Abstracts of 16the Central- and Eastern European Proteomic Conference, Praha 29.9.-1.10.2022, FrO-16. 2022.
      URL
      English. Czech Republic.
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 26/11/2022 00:09.
      More: https://is.muni.cz/publication/2234238/en

    2021

    1. A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
      LAPČÍK, Petr, Lucia JANÁČOVÁ, Pavla BOUCHALOVÁ, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues. In 20th Human Proteome Organization World Congress, HUPO Reconnect 2021, Online, 15.11.-19.11.2021, in Book of Abstracts, p. 184. 2021.
      URL
      Name in Czech: Rozsáhlá knihovna cílených hmotnostně-spektrometrických assays pro kvantifikaci proteinů v tkáních renálního karcinomu
      English. United States of America.
      Keywords in English: assay library, data independent acquisition, mass spectrometry, proteomics, renal cell carcinoma
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: Mgr. Petr Lapčík, Ph.D., učo 409180. Changed: 9/2/2022 16:37.
      More: https://is.muni.cz/publication/1816739/en
    2. DIA-MS Identifies and Validates Transgelin as Protein Contributing to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
      BOUCHALOVÁ, Pavla, Jindřich BERÁNEK, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Milan HORA, Ondřej FIALA, Alexandr POPRACH and Pavel BOUCHAL. DIA-MS Identifies and Validates Transgelin as Protein Contributing to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. In HUPO Reconnect 2021. 2021.
      URL
      Name in Czech: DIA-MS analýza identifikovala a validovala transgelin jako protein přispívající ke slabé odpovědi na léčbu sunitinibem u metastatického karcinomu ledvin
      English. United States of America.
      Keywords in English: renal carcinoma, sunitinib, resistance, DIA proteomics, transgelin, silencing technique, proliferation, survival
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 28/1/2022 12:39.
      More: https://is.muni.cz/publication/1804898/en
    3. Proteotypová analýza renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi (Proteotype analysis of renal cell carcinoma in relationship to prognosis and therapy response)
      LAPČÍK, Petr, Pavla BOUCHALOVÁ, Lucia JANÁČOVÁ, David POTĚŠIL, Ján PODHOREC, Milan HORA, Alexandr POPRACH, Ondřej FIALA and Pavel BOUCHAL. Proteotypová analýza renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi (Proteotype analysis of renal cell carcinoma in relationship to prognosis and therapy response). In 7. Neformální proteomické setkání, 25.-26.11.2021, Hradec Králové, In Book of Abstracts, p. 24. 2021.
      Name (in English): Proteotype analysis of renal cell carcinoma in relationship to prognosis and therapy response

      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 28/1/2022 13:06.
      More: https://is.muni.cz/publication/1828337/en
    4. SWATH-MS identifikácia stathminu ako potenciálneho markeru nádorov endometria u pacientok liečených tamoxifenom analýzou FFPE tkanív (SWATH-MS identification of stathmin as a potential marker of endometrial tumors in patients treated with tamoxifen in FFPE tissue analysis)
      JANÁČOVÁ, Lucia, Jakub FAKTOR, Lenka ČÁPKOVÁ, Vendula PÁRALOVÁ, Anna POSPÍŠILOVÁ, Ján PODHOREC, Ebhardt HOLGER ALEXANDER, Roman HRSTKA, Rudolf NENUTIL, Aebersold RUEDI and Pavel BOUCHAL. SWATH-MS identifikácia stathminu ako potenciálneho markeru nádorov endometria u pacientok liečených tamoxifenom analýzou FFPE tkanív (SWATH-MS identification of stathmin as a potential marker of endometrial tumors in patients treated with tamoxifen in FFPE tissue analysis). In Neformální proteomické setkání, 25.-26.11.2021, in Book of Abstracts, p. 17. 2021. 2021.
      URL
      Name in Czech: SWATH-MS identifikace stathminu jako potenciálního markeru nádorů endometria u pacientek léčených tamoxifenem analýzou FFPE tkání
      Name (in English): SWATH-MS identification of stathmin as a potential marker of endometrial tumors in patients treated with tamoxifen in FFPE tissue analysis

      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 28/1/2022 12:41.
      More: https://is.muni.cz/publication/1816341/en
    5. Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
      BOUCHALOVÁ, Pavla, Jindřich BERÁNEK, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Alexandr POPRACH and Pavel BOUCHAL. Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. Biomedicines. Basel: MDPI, 2021, vol. 9, No 9, p. 1145-1163. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines9091145.
      URL
      Name in Czech: Transgelin přispívá ke slabé odpovědi metastatického renálního karcinomu na léčbu sunitinibem
      RIV/00216224:14310/21:00120144 Article in a journal. English. Switzerland.
      Bouchalová, Pavla (203 Czech Republic, belonging to the institution) -- Beránek, Jindřich (203 Czech Republic, belonging to the institution) -- Lapčík, Petr (203 Czech Republic, belonging to the institution) -- Potěšil, David (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Poprach, Alexandr (203 Czech Republic, belonging to the institution) -- Bouchal, Pavel (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: mccRCC; sunitinib; resistance; DIA-MS; transgelin
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 28/2/2022 08:12.
      More: https://is.muni.cz/publication/1795618/en

    2020

    1. Transgelin contributes to a poor response of metastatic renal cell carcinoma to sunitinib treatment
      BOUCHALOVÁ, Pavla, Jindřich BERÁNEK, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Alexandr POPRACH and Pavel BOUCHAL. Transgelin contributes to a poor response of metastatic renal cell carcinoma to sunitinib treatment. In In Book of Abstract of: 19th Human Proteome Organization World Congress, HUPO Connect 2020, October 19-22, 2020, p. 45. 2020.
      URL
      Name in Czech: Transgelin přispívá ke slabé odpovědi metastatického renálního karcinomu na léčbu sunitinibem
      English. Sweden.
      Keywords in English: renal carcinoma, sunitinib, resistance, DIA proteomics, transgelin
      Type of participation: active participation (giving a lecture, organization, etc.)
      International impact: yes
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 27/1/2021 16:27.
      More: https://is.muni.cz/publication/1727645/en
    2. Transgelin negativně přispívá k léčebné odpovědi pacientů s metastatickým reálním karcinomem léčených tyrosinkinasovými inhibitory
      BOUCHAL, Pavel, Pavla BOUCHALOVÁ, Jindřich BERÁNEK, Petr LAPČÍK, David POTĚŠIL, Ján PODHOREC, Ondřej FIALA and Alexandr POPRACH. Transgelin negativně přispívá k léčebné odpovědi pacientů s metastatickým reálním karcinomem léčených tyrosinkinasovými inhibitory. In Book of Abstract of: Neformální proteomický webinář. 27.11.2020, str. 10. 2020.
      URL
      Czech. Czech Republic.
      Keywords in English: renal cell carcinoma, sunitinib, resistance, DIA proteomics, transgelin
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 27/1/2021 16:26.
      More: https://is.muni.cz/publication/1731064/en

    2019

    1. AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy.
      MARTIŠOVÁ, Andrea, Lucia SOMMEROVÁ, Katarina KURICOVA, Ján PODHOREC, Bořivoj VOJTĚŠEK, Katerina KANKOVA and Roman HRSTKA. AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy. ONCOLOGY LETTERS. GREECE: SPANDIDOS PUBL LTD, 2019, vol. 18, No 5, p. 4964‐4973. ISSN 1792-1074. Available from: https://dx.doi.org/10.3892/ol.2019.10800.
      Changed by: Mgr. Andrea Martišová, učo 451860. Changed: 20/9/2022 11:16.
      More: https://is.muni.cz/publication/1677699/en
    2. Méně časté mutace EGFR v kontextu léčby nemalobuněčného karcinomu plic (Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment)
      BÍLEK, Ondřej, Miloš HOLÁNEK, J. BERKOVCOVÁ, O. HORKÝ, Tomáš KAZDA, Helena ČOUPKOVÁ, Stanislav ŠPELDA, L. KRISTKOVÁ, Mária ZVARÍKOVÁ, Ján PODHOREC, Simona BOŘILOVÁ, Lucia BOHOVICOVÁ and Lenka ZDRAŽILOVÁ DUBSKÁ. Méně časté mutace EGFR v kontextu léčby nemalobuněčného karcinomu plic (Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment). Klinická onkologie. Praha: Ambit Media a.s., 2019, vol. 32, Supplementum 3, p. "3S6"-"3S12", 7 pp. ISSN 0862-495X. Available from: https://dx.doi.org/10.14735/amko20193S6.
      URL
      Name (in English): Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment
      RIV/00216224:14110/19:00118131 Article in a journal. Czech. Czech Republic.
      Bílek, Ondřej (203 Czech Republic, belonging to the institution) -- Holánek, Miloš (203 Czech Republic, belonging to the institution) -- Berkovcová, J. (203 Czech Republic) -- Horký, O. (203 Czech Republic) -- Kazda, Tomáš (203 Czech Republic, belonging to the institution) -- Čoupková, Helena (203 Czech Republic, belonging to the institution) -- Špelda, Stanislav (203 Czech Republic, belonging to the institution) -- Kristková, L. (203 Czech Republic) -- Zvaríková, Mária (703 Slovakia, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Bořilová, Simona (703 Slovakia, belonging to the institution) -- Bohovicová, Lucia (203 Czech Republic, belonging to the institution) -- Zdražilová Dubská, Lenka (203 Czech Republic, guarantor, belonging to the institution)
      Keywords in English: EGFR mutations; Epidermal growth factor receptor; Molecular targeted therapy; Non-small cell lung cancer; Tyrosine kinase inhibitors
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/5/2021 14:44.
      More: https://is.muni.cz/publication/1739696/en
    3. SWATH-MS identifikácia calcyphosinu a stathminu-1 ako markerov agresivity nádorov endometria s odlišnou špecifitou (SWATH-MS analysis identifies calcyphosin and stathmin as markers of endometrial cancer aggressiveness with a different specificity)
      JANÁČOVÁ, Lucia, Jakub FAKTOR, Lenka ČÁPKOVÁ, Anna POSPÍŠILOVÁ, Ján PODHOREC, H. Alexander EBHARDT, Roman HRSTKA, Rudolf NENUTIL and Pavel BOUCHAL. SWATH-MS identifikácia calcyphosinu a stathminu-1 ako markerov agresivity nádorov endometria s odlišnou špecifitou (SWATH-MS analysis identifies calcyphosin and stathmin as markers of endometrial cancer aggressiveness with a different specificity). In 6. Neformální proteomické setkání, Olomouc, 29.11.-30.11.2019, in Book of Abstracts, p. 20. 2019.
      URL
      Name in Czech: SWATH-MS identifikace calcyphosinu a stathminu-1 jako markerů agresivity nádorů endometria s odlišnou specifitou
      Name (in English): SWATH-MS analysis identifies calcyphosin and stathmin as markers of endometrial cancer aggressiveness with a different specificity
      Czech. Czech Republic.
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: doc. Mgr. Pavel Bouchal, Ph.D., učo 8757. Changed: 3/12/2019 09:52.
      More: https://is.muni.cz/publication/1586777/en

    2017

    1. Příčiny malnutrice.
      TUČEK, Štěpán, Jiří TOMÁŠEK, Ján PODHOREC and Jana HALÁMKOVÁ. Příčiny malnutrice. Klinická onkologie. Ambit Media a.s., 2017, p. 63. ISSN 0862-495X.
      Changed by: MUDr. Štěpán Tuček, Ph.D., učo 20613. Changed: 12/5/2018 01:51.
      More: https://is.muni.cz/publication/1416744/en
    2. Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.
      HRSTKA, Roman, Ján PODHOREC, Rudolf NENUTIL, Lucia SOMMEROVÁ, Joanna Agnieszka OBACZ, Michal ĎURECH, Jakub FAKTOR, Pavel BOUCHAL, Hana SKOUPILOVÁ and Bořivoj VOJTĚŠEK. Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells. Cancer Investigation. Marcel Dekker, 2017, vol. 35, No 5, p. 313-324. ISSN 0735-7907. Available from: https://dx.doi.org/10.1080/07357907.2017.1309546.
      URL
      Name (in English): Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.
      English. United States of America.
      Keywords in English: AGR2; Breast cancer; Endometrial cancer; Tamoxifen
      International impact: yes
      Reviewed: yes
      Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/4/2019 14:16.
      More: https://is.muni.cz/publication/1390162/en

    2016

    1. Dlouhodobá parciální remise metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika pacienta
      PODHOREC, Ján, Jiří TOMÁŠEK, Dagmar ADÁMKOVÁ KRÁKOROVÁ, Štěpán TUČEK, Pavel FABIAN, Michal STANDARA, Jiří VAŠINA and Igor KISS. Dlouhodobá parciální remise metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika pacienta. 2016, p. 2S87. ISSN 0862-495X.
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 28/4/2016 16:58.
      More: https://is.muni.cz/publication/1343704/en

    2015

    1. ANTERIOR GRADIENT PROTEIN 3 (AGR3) IS ASSOCIATED WITH LESS AGGRESSIVE TUMOURS AND BETTER OUTCOME OF BREAST CANCER PATIENTS
      OBACZ, Joanna Agnieszka, Veronika BRYCHTOVÁ, Ján PODHOREC, Pavel FABIAN, Petr DOBEŠ, Bořivoj VOJTĚŠEK and Roman HRSTKA. ANTERIOR GRADIENT PROTEIN 3 (AGR3) IS ASSOCIATED WITH LESS AGGRESSIVE TUMOURS AND BETTER OUTCOME OF BREAST CANCER PATIENTS. In XXXIX. Brněnské onkologické dny a XXIX. Konference pro nelékařské zdravotnické pracovníky. 2015.
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 23/7/2015 21:25.
      More: https://is.muni.cz/publication/1306850/en
    2. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
      OBACZ, Joanna Agnieszka, Veronika BRYCHTOVÁ, Ján PODHOREC, Pavel FABIAN, Petr DOBEŠ, Bořivoj VOJTĚŠEK and Roman HRSTKA. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients. Oncotargets Ther. 2015: Dovepress, 2015, No 8, p. 1523-1532. ISSN 1178-6930.

      Keywords in English: AGR3, patient survival, protein disulfide isomerase, ER-positive breast cancer, immuno­histochemistry
      International impact: yes
      Reviewed: yes
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 23/7/2015 20:53.
      More: https://is.muni.cz/publication/1306847/en
    3. Monogenní dědičné choroby. In Ondřej Slabý et al.: Molekulární medicína.
      PODHOREC, Ján and Iveta VALÁŠKOVÁ. Monogenní dědičné choroby. In Ondřej Slabý et al.: Molekulární medicína. Praha: Galén, 2015, p. 241-246. ISBN 978-80-7492-121-6.
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 23/7/2015 21:14.
      More: https://is.muni.cz/publication/1306849/en
    4. Onemocnění imunitního systému. In Ondřej Slabý et al.: Molekulární medicína.
      PODHOREC, Ján and Lukáš KUBALA. Onemocnění imunitního systému. In Ondřej Slabý et al.: Molekulární medicína. Praha: Galén, 2015, p. 327-347. ISBN 978-80-7492-121-6.
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 23/7/2015 21:10.
      More: https://is.muni.cz/publication/1306848/en

    2014

    1. Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.
      DOBEŠ, Petr, Ján PODHOREC, Oldřich COUFAL, Andrea JUREČKOVÁ, Katarína PETRÁKOVÁ, Bořivoj VOJTĚŠEK and Roman HRSTKA. Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients. Oncology Reports. Athens: National Hellenic Research Foundation, 2014, vol. 32, No 4, p. 1695-1702. ISSN 1021-335X.
      Oncology and haematology. English. Greece.
      International impact: yes
      Reviewed: yes
      Changed by: Soňa Böhmová, učo 232884. Changed: 26/4/2019 09:45.
      More: https://is.muni.cz/publication/1196721/en
    2. PŘÍPAD NEČEKANÉ A TRVAJÍCÍ LÉČEBNÉ ODPOVĚDI U EPITELOIDNÍHO SARKOMU
      TUČEK, Štěpán, Dagmar ADÁMKOVÁ KRÁKOROVÁ, Andrea JUREČKOVÁ, Lukáš POCHOP, Helena TUŠKOVÁ, Ján PODHOREC, Jana HALÁMKOVÁ and Jiří TOMÁŠEK. PŘÍPAD NEČEKANÉ A TRVAJÍCÍ LÉČEBNÉ ODPOVĚDI U EPITELOIDNÍHO SARKOMU. In Sborník abstrakt: XXXVIII. brněnské onkologické dny a XXVIII. konference pro nelékařská zdravotnické pracovníky. Brno: Masarykův onkologický ústav, 2014, p. 77-232. ISBN 978-80-86793-32-0.
      Changed by: MUDr. Štěpán Tuček, Ph.D., učo 20613. Changed: 10/7/2014 11:44.
      More: https://is.muni.cz/publication/1188471/en
    3. Regrese metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii- kazuistika
      PODHOREC, Ján, Jiří TOMÁŠEK, Igor KISS, Andrea JUREČKOVÁ, Štěpán TUČEK, Jana HALÁMKOVÁ, Lukáš POCHOP and Pavel FABIAN. Regrese metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii- kazuistika. In Sborník abstrakt: XXXVIII. brněnské onkologické dny a XXVIII. konference pro nelékařská zdravotnické pracovníky. 1st ed. Brno: Masarykův onkologický ústav, 2014, p. 103-103, 156 pp. ISBN 978-80-86793-32-0.
      Oncology and haematology. Czech. Czech Republic.
      Type of proceedings: pre-proceedings
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 6/7/2014 20:56.
      More: https://is.muni.cz/publication/1181086/en

    2013

    1. Maligní melanom léčený intenzivní chemoterapií, podobnost histologického obrazu maligního melanomu a nádorů měkkých tkání, kazuistika pacientky (Malignant melanoma treated with radical chemotherapy, resemblance histology of melanoma to soft tissue sarcomas, case report)
      BÍLEK, Ondřej, Štěpán TUČEK, Karel VESELÝ, Pavel FABIAN, Blanka ROBEŠOVÁ, Dagmar ADÁMKOVÁ KRÁKOROVÁ, Radek LAKOMÝ, Marek SVOBODA, A. JUREČKOVÁ, Jana HALÁMKOVÁ, J. KRÁLOVÁ, Lucia ŠIKULÍNCOVÁ, Ján PODHOREC, Jiří TOMÁŠEK, Igor KISS and Rostislav VYZULA. Maligní melanom léčený intenzivní chemoterapií, podobnost histologického obrazu maligního melanomu a nádorů měkkých tkání, kazuistika pacientky (Malignant melanoma treated with radical chemotherapy, resemblance histology of melanoma to soft tissue sarcomas, case report). Klinická onkologie. Praha: Česká lékařská společnost J.E.Purkyně, 2013, vol. 26, No 1, p. 42-46. ISSN 0862-495X.
      Name (in English): Malignant melanoma treated with radical chemotherapy, resemblance histology of melanoma to soft tissue sarcomas, case report
      RIV/00216224:14110/13:00068047 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Bílek, Ondřej (203 Czech Republic, guarantor) -- Tuček, Štěpán (203 Czech Republic) -- Veselý, Karel (203 Czech Republic) -- Fabian, Pavel (203 Czech Republic, belonging to the institution) -- Robešová, Blanka (203 Czech Republic, belonging to the institution) -- Adámková Krákorová, Dagmar (203 Czech Republic) -- Lakomý, Radek (203 Czech Republic) -- Svoboda, Marek (203 Czech Republic) -- Jurečková, A. (203 Czech Republic) -- Halámková, Jana (203 Czech Republic, belonging to the institution) -- Králová, J. (203 Czech Republic) -- Šikulíncová, Lucia (703 Slovakia) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Tomášek, Jiří (203 Czech Republic) -- Kiss, Igor (203 Czech Republic) -- Vyzula, Rostislav (203 Czech Republic)
      Keywords in English: malignant melanoma; chemotherapy; PAX7-FKHR
      Reviewed: yes
      Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 28/3/2014 11:31.
      More: https://is.muni.cz/publication/1094892/en
    2. Pacient s metastatickým kolorektálním karcinomem léčený multimodálním přístupem
      JUREČKOVÁ, Andrea, Jiří TOMÁŠEK, Rostislav VYZULA, Igor KISS, Štěpán TUČEK, Lucia ŠIKULÍNCOVÁ and Ján PODHOREC. Pacient s metastatickým kolorektálním karcinomem léčený multimodálním přístupem. Acta medicinae. Praha, 2013, vol. 2, p. 22-25. ISSN 1805-398X.
      Changed by: MUDr. Štěpán Tuček, Ph.D., učo 20613. Changed: 10/7/2014 12:49.
      More: https://is.muni.cz/publication/1188476/en
    3. The liver function assessment – The indocyanine green retention in correlation with the cholescintigraphic measurement: A retrospective validation study in 107 patients with liver malignancies.
      TOMÁŠEK, Jiří, Igor KISS, Jiří PRÁŠEK, Ladislav DUŠEK, Štěpán TUČEK, Vlastimil VÁLEK, Rostislav VYZULA, Zdeněk KALA, Iveta ZIMOVÁ, Ján PODHOREC, Jana HALÁMKOVÁ and Dagmar ADÁMKOVÁ KRÁKOROVÁ. The liver function assessment – The indocyanine green retention in correlation with the cholescintigraphic measurement: A retrospective validation study in 107 patients with liver malignancies. In 10 th Gastrointestinal Cancers Symposium, ASCO, ASTRO, SSO, San Francisco, USA. 2013.
      Name (in English): The liver function assessment – The indocyanine green retention in correlation with the cholescintigraphic measurement: A retrospective validation study in 107 patients with liver malignancies.
      RIV/00216224:14110/13:00070938 Presentations at conferences. Oncology and haematology. Czech. Czech Republic.
      Tomášek, Jiří (203 Czech Republic, guarantor) -- Kiss, Igor (203 Czech Republic, belonging to the institution) -- Prášek, Jiří (203 Czech Republic, belonging to the institution) -- Dušek, Ladislav (203 Czech Republic, belonging to the institution) -- Tuček, Štěpán (203 Czech Republic, belonging to the institution) -- Válek, Vlastimil (203 Czech Republic, belonging to the institution) -- Vyzula, Rostislav (203 Czech Republic, belonging to the institution) -- Kala, Zdeněk (203 Czech Republic, belonging to the institution) -- Zimová, Iveta (203 Czech Republic, belonging to the institution) -- Podhorec, Ján (703 Slovakia, belonging to the institution) -- Halámková, Jana (203 Czech Republic, belonging to the institution) -- Adámková Krákorová, Dagmar (203 Czech Republic, belonging to the institution)
      Keywords in English: liver function; TACE; RFA
      Type of participation: active participation (giving a lecture, organization, etc.)
      Changed by: MUDr. Jiří Tomášek, Ph.D., učo 56684. Changed: 12/1/2014 20:44.
      More: https://is.muni.cz/publication/1139542/en

    2012

    1. Hodnocení jaterní funkce v onkologické praxi (Liver function assessing in oncology practice)
      TOMÁŠEK, Jiří, Jiří PRÁŠEK, Igor KISS, Libuše HUSOVÁ and Ján PODHOREC. Hodnocení jaterní funkce v onkologické praxi (Liver function assessing in oncology practice). Klinická onkologie. Praha: Ambit Media a.s., 2012, vol. 25, No 6, p. 427-433. ISSN 0862-495X.
      URL
      Name in Czech: Hodnocení jaterní funkce v onkologické praxi
      Name (in English): Liver function assessing in oncology practice
      RIV/00216224:14110/12:00062344 Article in a journal. Oncology and haematology. Czech. Czech Republic.
      Tomášek, Jiří (203 Czech Republic, guarantor, belonging to the institution) -- Prášek, Jiří (203 Czech Republic, belonging to the institution) -- Kiss, Igor (203 Czech Republic, belonging to the institution) -- Husová, Libuše (203 Czech Republic) -- Podhorec, Ján (703 Slovakia)
      Keywords in English: liver function tests; drug induced liver injury; indocyanine green; nuclear medicine
      Reviewed: yes
      Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 27/2/2013 06:25.
      More: https://is.muni.cz/publication/1078282/en
    2. The role of Anterior Gradient 2 in breast cancer signaling pathways
      HRSTKA, Roman, Pavla BOUCHALOVÁ, Veronika BRYCHTOVÁ, Eva MATOULKOVÁ, Lucia SOMMEROVÁ, Ján PODHOREC and bořivoj VOJTĚŠEK. The role of Anterior Gradient 2 in breast cancer signaling pathways. 30th ed. Athens: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, Supplement: 1 Meeting Abstract: 139, 2012, p. S14-S14, 1 pp. ISSN 1107-3756.

      Type of proceedings: post-proceedings
      Changed by: MUDr. Ján Podhorec, učo 141839. Changed: 23/7/2015 20:02.
      More: https://is.muni.cz/publication/1306846/en
Displayed: 7/5/2024 03:57